Safety and EffecTiveness of the Silk Vista Flow DiverteR in the TrEatment of Unruptured IntracrAnial AneurysMs
A legfontosabb adatok
- Ki végzi
- University Hospital, Bordeaux
- Hol
- Bordeaux (Franciaország)A helyszín megnézése
- Azonosító
- Állapot
- Toborzás még nem indult
- Résztvevők
- 100 fő, tervezett
- Kezdés
- 2025. szept.
- Várható befejezés
- 2027. dec.
- A vizsgálat típusa
- Megfigyeléses
- A vizsgált kezelések
- Endovascular treatment with placement of a flow-diverting stent
- A regiszteradat frissítve
- 2025. július 18.
Ki vehet részt
MI-összefoglaló
A vizsgálat saját részvételi feltételeiből. Gép olvasta ki az oldalon álló regiszterszövegből, ezért tévedhet. Hogy ki vehet részt, azt a lenti regiszterszöveg és a vizsgálat csapata dönti el.
The trial is looking for adults with a brain aneurysm (a bulge in a brain artery) that will be treated with the Silk Vista flow-diverter stent.
- Életkor
- 18 to 80 years
- Nem
- All
- A betegség stádiuma
- At least one unruptured brain aneurysm. The aneurysm may be untreated or reopened. An aneurysm that burst before can be included if it burst more than 30 days before the procedure.
- Korábbi kezelés
- People cannot join if earlier treatment of the target aneurysm or its artery would get in the way of placing the device.
A részvétel fő kizáró okai
- Cannot have treatment through the blood vessels or a flow-diverting stent, for example due to allergy to contrast dye, nickel, titanium, tungsten or platinum, or not being able to take blood-thinning platelet drugs
- Pregnant or breastfeeding
- Aneurysm sits right where a vessel splits in two
- Long-term blood-thinner treatment or a known bleeding disorder
- Bleeding in the brain within 30 days, or major surgery within 30 days or planned in the next 6 months
A regiszter feltételei, szó szerint
Mind a 20 feltétel megnézéseKevesebb
Ki vehet részt
- Age ≥ 18 and ≤ 80 years old,
- Patient has at least one unruptured intracranial aneurysm intended to be treated with Silk Vista
- Has an untreated or recanalized, unruptured or previously ruptured aneurysm whose rupture occurred >30 days prior to the index procedure
- Able and willing to comply with study procedures including returning to the study site for imaging exams
- Able and willing to give oral informed consent
Ki nem vehet részt
- Has vessel characteristics, such as severe tortuosity, stenosis, or morphology that would preclude safe endovascular access to the target aneurysm necessary for treatment with the study device
- Received previous treatment of the target aneurysm or parent artery where it would interfere with the placement or proper apposition of the device
- Subarachnoid hemorrhage unrelated to a ruptured target aneurysm which occurred within 30 days prior to enrollment
- Intracranial parenchymal hemorrhage occurred within 30 days prior to enrollment
- Major surgery (including previous intracranial implant) occurred within previous 30 days or is planned in the next 6 months after enrollment date
- Chronic anticoagulation therapy is ongoing or known coagulopathy exists
- Any criteria for non- or contraindication to endovascular treatment and/or flow-diverting stent placement (e.g., suspected mycotic aneurysm, including those caused by a left atrial myxoma, systemic bacterial infection, contraindication to antiplatelet drugs (aspirin, clopidogrel/Plavix, ticagrelor, and heparin), local or general anesthesia, allergy to the contrast agent required for treatment by the diversion technique, known severe allergy or hypersensitivity to nickel, titanium, tungsten, or platinum; cost of treatment for an intracranial aneurysm within the last 6 months; and for women, pregnant, or currently breastfeeding)
- Presence of intracranial atherosclerotic disease
- Presence of intracranial mass (tumor, except meningioma, abscess, or other infection), non-treated arteriovenous malformation (AVM) in the territory of the target aneurysm
- Has a true bifurcation aneurysm, defined as an aneurysm (saccular or non-saccular) located at a point of vessel bifurcation
- Has more than one known IA that is anticipated to require treatment within 6 months of the index procedure
- Patient has a serious or life-threatening comorbidity that could confound study results
- Participation in any other investigational study which may interfere with collection of valid data under this study or may influence study endpoints Unable to complete study follow up (12 months) due to geographical distance
- Unable to understanding study
- Under legal protection
A fő feltételek kérdésként
Magadról válaszolj. Ez nem döntés: hogy részt vehetsz-e, azt csak a vizsgálat csapata mondhatja meg.
- 18 és 80 év között vagy?
Helyszínek itt: Franciaország
- CHU BordeauxBordeaux, FranciaországContact: Omer Eker, MD, PhDToborzás még nem indult
A vizsgálatról
Mit akar kideríteni a vizsgálat
Intracranial aneurysms (IA) are abnormal outpouchings of cerebral arteries' walls that occur mostly in arteries found in the Circle of Willis and the middle cerebral artery bifurcation with a risk of rupture leading to subarachnoid hemorrhage (SAH) and potentially death. If IA is treated before rupture, survival rates improve dramatically. The IA can be treated with endovascular technique (coiling or stenting). Specifically, the parent artery reconstruction with a flow-diverter stent allows the treatment of a wide range of aneuryms with high rate of aneurysm occlusion. However, during follow-up, up to 15% of FD present deformities, associated with increased morbidity secondary to implant. This phenomenon is not predictable and its mechanism remains unexplained. The objective of this STREAM study is to generate longitudinal clinical and imaging data on the Silk Vista to further evaluate its efficacy and safety in the treatment of unruptured IA, and in particular, to assess and understand the impact of morphological changes over time associated with this device
A vizsgálat csoportja
- Patients with unruptured intracranial aneurysm
Patients aged ≥ 18 and ≤ 80 years old, with at least one unruptured intracranial aneurysm intended to be treated with Silk Vista
Kezelés: Endovascular treatment with placement of a flow-diverting stent
Kérdések a vizsgálat csapatának
- Milyen gyakran kell bejárnom, és egy-egy alkalom mennyi ideig tart?
- Megtérítik az utazási költséget?
- Megtarthatom a saját orvosomat?
- Mi történik, ha ki akarok lépni?
Contact the study team: see the registry record → Contacts and Locations
Oldal nyomtatása az orvosomnakAdatok és források
- Regiszteradat
- Szerepel a ClinicalTrials.gov-on.
- MI-összefoglaló
- A vizsgálat saját részvételi feltételeiből. Gépi kiolvasás: 2026. november 14.
- Kérdések a feltételekről
- Forrás: NCT07073118: ki vehet részt
- A regiszteradat frissítve
- 2025. július 18.